Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Sep 8, 2017

Sanofi and Regeneron Announce That Cemiplimab (REGN2810) Has Received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma
Sep 1, 2017

Sanofi Receives Tentative FDA Approval of Admelog® (insulin lispro injection) 100 Units/mL
Aug 28, 2017

Sanofi completes the acquisition of Protein Sciences

- An innovative quadrivalent influenza vaccine will complement Sanofi Pasteur vaccine portfolio -
Aug 25, 2017

Sanofi and Regeneron to Present New Analyses from Praluent® (alirocumab) Injection Trials at the ESC Congress 2017
Aug 8, 2017

Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus®

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.